Gene Query: BARX2

Dataset Description Geneva Score
Transcripotome analysis of different locations of hair follicles (bulb, bulge) in androgenetic alopecia 73.78
Gene expression alterations associated with acquired-resistance to the CDK4/6 inhibitor palbociclib [Palbociclib resistance_RNASeq] 60.11
Identifying a novel candidate diagnostic and prognostic biomarker SPRR3 for oral squamous cell carcinoma via mRNA Sequencing and Bioinformatics 42.77
The role of FAM46C in myeloma cells 31.22
The role of FAM46C in myeloma cells [sequencing] 31.22
Integrative analysis of mRNA and lncRNA profiles identified pathogenetic lncRNAs in esophageal squamous cell carcinoma 29.37
Analysis and expansion of the eosinophilic esophagitis transcriptome by RNA sequencing 24.69
Subclonal cooperation drives metastasis through modulating local and systemic immune microenvironments 21.61
Research resource: global identification of estrogen receptor β target genes in triple negative breast cancer cells 18.55
Regulation of PRMT5-MDM4 axis is critical in the response to CDK4/6 inhibitors in melanoma 17.62
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques 15.7
GCTM-5 positive and negative cells in pancreatic adenocarcinoma cell lines 14.74
Long non-coding RNA RP11-19E11.1 is an E2F1 target required for tumor cell proliferation and survival in basal breast cancer 13.82
RNA-Seq in two Ewing sarcoma cell lines: A673 and SKNMC 13.37
siRNA-mediated silencing of ORAI3 in MDA-MB-468 breast cancer cells exposed to hypoxia 12.85
Targeted degradation of BRD9 reverses oncogenic gene expression in synovial sarcoma [RNA-seq] 12.73
Targeted degradation of BRD9 reverses oncogenic gene expression in synovial sarcoma 12.73
An Open-Label Pilot Study to Evaluate the Efficacy of Tofacitinib in Moderate to Severe Patch Type Alopecia Areata, Totalis and Universalis 11.94
Expression profiling by high throughput sequencing of tumors derived from human prostate epithelial cells transformed with the oncogenes N-Myc and myrAKT1. 11.93
A common cell state in Triple Negative Breast Cancers represents a druggable vulnerability 11.67
POU2AF1 Functions in the Human Airway Epithelium to Regulate Expression of Host Defense Genes 10.71
POU2AF1 Functions in the Human Airway Epithelium to Regulate Expression of Host Defense Genes [RNA-Seq] 10.71
RNA sequence analysis of stable versus reversible EMT events and the resultant metastases 10.16
Genes regulated by SPDEF or FOXA3 in A549 lung carcinoma cells [RNA-seq] 9.77
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and SMAD4 Y95 Mutation Transcriptomes 9.73
Major roles of cyclobutane pyrimidine dimers, nucleotide excision repair and ATR in the alternative splicing response to UV irradiation 9.61
Transcriptional Targeting Of Oncogene Addiction In Medullary Thyroid Cancer 9.52
Transcriptional Targeting Of Oncogene Addiction In Medullary Thyroid Cancer [RNA-Seq] 9.52
Transcriptome profiles of moderate dysplasia in oral mucosa associated with malignant conversion 9.51
The role of PHF19 in promoting H3K27me3 deposition in multiple myeloma 9.39
The role of PHF19 in promoting H3K27me3 deposition in multiple myeloma (RNA-Seq) 9.39
Effects on gene expression of ibrutinib treatment in human stem cells-derived atrial- and ventricular-like cardiomyocytes 9.37
Directed differentiation of human embryonic stem cells to corneal endothelial cell-like cells: A transcriptomic analysis 9.33
The SS18-SSX oncoprotein hijacks KDM2B-PRC1.1 to drive synovial sarcoma [RNA-seq] 8.89
The SS18-SSX oncoprotein hijacks KDM2B-PRC1.1 to drive synovial sarcoma 8.89
Tracing transcriptome profiles of human oocyte cultured by growth hormone or not in vitro by single cell RNA-seq 8.32
Effect of selective glucocorticoid receptor modulation (SGRM) on gene expression in human prostate cancer cell lines 7.79
3D genome of multiple myeloma reveals spatial genome disorganization associated with copy number variations 7.6
Expression by CD133+ cells isolated from the adult human exocrine pancreas 7.59
RNA-seq of Human neck of femur (NOF) fracture hip and osteoarthritic (OA) cartilage 7.35
Long noncoding RNA ROCR contributes to SOX9 expression and chondrogenic differentiation of human mesenchymal stem cells 7.35
Next-generation sequencing analysis of transcriptom in gemcitabine resistant pancreatic cancer cells 6.91
Transcriptomics profiles of patient-matched normal kidney and ccRCC pairs 6.76
Identification of an NKX3.1-G9a-UTY regulatory network that controls prostate differentiation 6.67
Identification of an NKX3.1-G9a-UTY regulatory network that controls prostate differentiation (Human_RWPE1_RNA-Seq) 6.67
Anaylsis of the effect of down-regulation of the EWS-FLI1 fusion protein in Ewing Sarcoma cells by RNA-seq. 6.62
Vitamin d receptor-mediated stromal reprogramming suppresses pancreatitis and enhances pancreatic cancer therapy 6.53
The IMiDs, through loss of Ikaros and Aiolos, primes myeloma cells for daratumumab mediated killing by upregulation of CD38 5.73
Exploring the gene expression profile upon FXR1 knockdown in H358 cells using RNA-seq 5.63
Genome-wide profiling of siRNA targeting EWS-FLI1 in TC32 Ewing sarcoma cell line 5.21
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells 5.06
Human induced pluripotent stem cell-derived vocal fold mucosa mimics development and responses to smoke exposure 4.99
Stem cell and neurogenic gene-expression profiles link prostate basal cells to aggressive prostate cancer 4.9
A practical evaluation of alignment algorithms for RNA variant calling analysis 4.53
Novel Form of JARID2 is Required to Regulate Differentiation in Keratinocytes. 4.46
Molecular pathogenesis of human prostate basal cell hyperplasia reveals a keratinocyte metaplasia 4.39
LIN28A modulates splicing and gene expression programs in breast cancer cells [RNA-Seq] 4.17
LIN28A modulates splicing and gene expression programs in breast cancer cells 4.17
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques [MB157_RNA-seq] 4.08
EWS-Fli and LNC regulated genes in comparison to GFP samples 3.99
Therapeutic targeting of KDM1A/LSD1 in Ewing sarcoma engages the ER-stress response II 3.93
RNA-seq analysis of FET cells treated with RSPO1 or TGFβ1 3.92
The SPOP-containing Complex Functions as an E3 Ligase for SETD2 to Regulate Gene-Specific H3K36me3-Coupled Alternative Splicing 3.8
Investigate A2M treatment on human prostate cancer and mouse liver 3.8
Investigate A2M treatment on human prostate cancer xenograft in mice 3.8
Nuclear receptor RORγ is a targetable master regulator of cholesterol in a subtype of breast cancer 3.77
Nuclear receptor RORγ is a targetable master regulator of cholesterol in a subtype of breast cancer [RNA-Seq] 3.68
Pervasive transcription read-through promotes aberrant expression of oncogenes and RNA chimeras in renal carcinoma 3.55
The m 6 A-methylase complex recruits TREX and regulates mRNA export. 3.41
A Novel PI3K Regulator, ARID4B, Presents Synthetic Essentiality in PTEN-deficient Prostate Cancer 3.17
A Novel PI3K Regulator, ARID4B, Presents Synthetic Essentiality in PTEN-deficient Prostate Cancer [RNA-seq] 3.17
RNAseq analysis of ruxolitinib treated breast cancers 3.16
Distinct Roles of BET Family Members in ERα Enhancer Function and Gene Regulation in Breast Cancer Cells 3.02
Distinct Roles of BET Family Members in ERα Enhancer Function and Gene Regulation in Breast Cancer Cells [RNA-seq] 3.02
RNA sequencing for lncRNA, miRNA and mRNA expression analysis in human laryngeal cancer 2.99
Conserved roles for murine mDUX and human DUX4 in activating cleavage stage genes and MERVL/HERVL retrotransposons [RNA-Seq] 2.95
Generation of Patient-Matched Malignant and Normal Primary Cell Cultures from Clear Cell Renal Cell Carcinoma Patients 2.88
Reconstituting development of pancreatic intraepithelial neoplasia from primary human pancreas duct cells 2.83
Long non-coding RNA expression profile associated with malignant progression of oral submucous fibrosis 2.81
Genome-wide transcriptome analysis of organotypic rafts derived from human papillomavirus type 16 infected primary keratinocytes [3D raft] 2.79
Impact of GDF15 expression of ovarian cancer cell on stroma and Cisplatin responses 2.78
Patient-derived xenograft models of non-small cell lung cancer for evaluating targeted drug sensitivity and resistance 2.74
ERK potentiates transactivation and oncogenic function of ERG by phosphorylation induced dissociation of PRC2 complex 2.65
RNA-Seq of Kaposi’s sarcoma reveal alterations in glucose and lipid metabolism 2.57
RC3H1 posttranscriptionally regulates A20 mRNA and modulates the activity of the IKK/NF-kB pathway 2.52
RC3H1 posttranscriptionally regulates A20 mRNA and modulates the activity of the IKK/NF-kB pathway [RNA-Seq] 2.52
Sequencing-based analyses characterize a tumor suppressive role of mir-1271 repressed by DNA hypermethylation in gastric cancer 2.51
Wnt addiction of genetically defined cancers reversed by PORCN inhibition 2.5
Knockdown of FOXP1 promotes the development of lung adenocarcinoma 2.48
Transciptome profiling of NoDice and RNaseIII null cells prior to and after polyIC treatment 2.4
The phosphatidylinositol 3-kinase pathway as a potential therapeutic target in bladder cancer 2.4
Ets homologous factor has critical roles in epithelial dysfunction in airway disease 2.38
Ets homologous factor has critical roles in epithelial dysfunction in airway disease [RNA-seq] 2.38
High-throughput RNAi cell viability screen to identify selective targets for EWS-FLI1 positive Ewing sarcoma 2.37
mRNA-sequencing of breast cancer subtypes and normal tissue 2.34
Paclitaxel plus Cirmtuzumab Achieves Greater Clearance of Patient-derived Xenografts By Targeting ROR1+ Breast Cancer Stem Cells 2.31
Genome-wide identification of cancer-specific alternative splicing in circRNA 2.27
Altered mRNA splicing by mutant p53 activates oncogenic RAS in pancreatic cancer 2.19
Transcriptome sequencing of differentially expressed genes in mouse and human skin with and without NCSTN mutation 2.18
Transcriptome sequencing of differentially expressed genes in acne inversa (AI) patients with NCSTN mutation and healthy individuals 2.18
Single Cell RNA-sequencing of cell types isolated by FACS from normal human prostates 2.14
Distinct regulation of alternative polyadenylation and gene expression by nuclear poly(A) polymerases 2.14
Dynamic and stable enhancer-promoter contacts regulate terminal differentiation [RNA-Seq] 2.14
Dynamic and stable enhancer-promoter contacts regulate terminal differentiation 2.14
Transcription factors OVOL1 and OVOL2 induce the mesenchymal to epithelial transition in human cancer 2.14
Global epigenomic reconfiguration during mammalian brain development 2.13
5hmC and gene expression data in breast cancer cell lines treated with an antioxidant 2.12
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [BAA] 2.08
Transcriptional Regulationand Chromatin Dynamics inHuman Epithelial Cell Differentiation 2.08
Transcriptional Regulationand Chromatin Dynamics inHuman Epithelial Cell Differentiation (RNA-seq) 2.08
Enriched EWSR1 and EWS-FLI1 RNA-seq of HNRNPH1-silenced TC32 Ewing sarcoma and 293T human embryonic kidney cells. 2.07
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [UNSWCD] 2.0
Genome-wide chromatin analysis of Ewing sarcoma 1.94
Genome-wide chromatin analysis of Ewing sarcoma (RNA-seq) 1.94
The role of miR-17-92 in the miRegulatory landscape of Ewing Sarcoma (RNA-Seq) 1.93
The role of miR-17-92 in the miRegulatory landscape of Ewing Sarcoma 1.93
Cooperation of dominant oncogenes with regulatory variants shapes clinical outcomes in pediatric cancer 1.92
RNA-seq of three Ewing sarcoma cell lines (A673, SK-N-MC, RDES), transfected with either siControl or siMYBL2. 1.92
Ewing sarcoma resistance to SP-2509 is not mediated through KDM1A/LSD1 mutation II 1.9
Integrated Profiling of mRNAs and microRNAs to Identify Potential Biomarkers for Oral Malignant Transformation 1.85
Integrated Profiling of mRNAs and microRNAs to Identify Potential Biomarkers for Oral Malignant Transformation [mRNA-Seq] 1.85
Transcriptomic profiling of O-GlcNAcylated mRNA-protein complexes by using OG-CLAP in HeLa cells. 1.83
Electronic cigarettes 1.83
Multiple roles for Grainyheadlike transcription factors in the establishment and maintenance of human mucociliary airway epithelium 1.82
Gene expression profile of human multiple myeloma cell line MM.1S after knockdown of KDM6B 1.8
RNA-seq analysis and shRNA screen of breast cancer 1.8
RNA-seq analysis of breast cancer 1.8
Transcriptome of human keratinocytes with or without HPV16 oncogene expression 1.8
Analysis Of The TGFb-Induced Program In Primary Airway Epithelial Cells Shows Essential Role Of NF-kB/RelA Signaling Network In Type II Epithelial Mesenchymal Transition 1.75
SREBP1 drives Keratin 80-dependent cytoskeletal changes and invasive behavior in endocrine resistant ERα breast cancer 1.7
Short and long-term effects of CDK4/6 inhibition on early stage breast cancer 1.66
G9a-Mediated Methylation of ERα Links the PHF20/MOF Histone Acetyltransferase Complex to Hormonal Gene Expression 1.63
Transcriptome analysis of PC9 cells with gefitinib or/and hypoxia treatment and comparison with gefitinib resistant PC9 cells and ALDH positive PC9 cells 1.6
Transcriptomic analysis of frontal fibrosing alopecia 1.56
Sequencing of ponatinib-resistant LC-2/ad derivatives (PR1 and PR2) and parental LC-2/ad cells 1.56
Gene expression profile of multiple myeloma cell lines treated with CB-5083 1.56
Dissecting the dynamics of signaling events in the BMP,WNT and NODAL cascade during self-organized fate patterning in human gastruloids 1.55
Transcriptional profiling of MCF7 cells treated with H3B05942, E2, or standard of care compounds 1.51
Targetting super enhancer associated oncogenes in esophageal squamous cell carcinoma [RNA-seq] 1.5
Targetting super enhancer associated oncogenes in esophageal squamous cell carcinoma 1.5
TOP2B disturbed the quality of human oocytes with advanced maternal age 1.5
The SS18-SSX fusion oncoprotein hijacks BAF complex targeting and function to drive synovial sarcoma [RNA-Seq Tumor] 1.49
Transcriptional differences between skin from patients with atopic dermatitis and control skin obtained from the healthy margins of Mohs surgery patients 1.49
Global analysis of alternative splicing regulated by RBM10 1.46
An interaction with Ewing's sarcoma breakpoint protein EWS defines the specific oncogenic mechanism of ETS factors rearranged in prostate cancer 1.42
Next Generation Sequencing Facilitates Quantitative Analysis of Retinoblastoma Transcriptomes 1.4
Diverse AR-V7 cistromes in castration-resistant prostate cancer are governed by HoxB13 1.39
PR isoform-specific ER and PR chromatin binding and gene expression observed in-vitro in breast cancer cells. 1.37
Priming mobilization of hair follicle stem cells triggers permanent loss of regeneration after alkylating chemotherapy 1.36
Image based identification and targeting of cancer stem cells in pancreatic adenocarcinoma (PDAC) 1.36
Inhibiting the oncogenic translation program is an effective therapeutic strategy in multiple myeloma 1.33
Targeting FOXA1-mediated repression of TGF-β signaling suppresses castration-resistant prostate cancer progression 1.29
Targeting FOXA1-mediated repression of TGF-β signaling suppresses castration-resistant prostate cancer progression [RNA-Seq] 1.29
A SIRT1-centered Circuitry Regulates Breast Cancer Stemness and Metastasis 1.26
Biological effect of chronic mistranslation in mammalian cells 1.26
Transcription factors and stress response gene alterations in human keratinocytes following Solar Simulated Ultra Violet Radiation 1.19
Effect of estrogen (E2) treatment on the C4-12 relative to the MCF7 cells 1.17
Gene expression profiles of isogenic single-cell derived clones of BRAF-mutated SK-MEL-5 melanoma cell lines 1.15
Fusion discovery in breast cancer cell line 1.12
A Phase II Study of Pomalidomide, Daily Low Dose Oral Cyclophosphamide, and Dexamethasone in Relapsed/Refractory Multiple Myeloma 1.12
Characterization of sperm lncRNA and its differently expression in the sperm of asthenozoospermic patients 1.11
ELF1 expression in prostate cells reduces oncogenic ETS functions and promotes senescence and sensitivity to chemotherapy through distinct gene expression programs [RNA-seq] 1.1
ELF1 expression in prostate cells reduces oncogenic ETS functions and promotes senescence and sensitivity to chemotherapy through distinct gene expression programs 1.1
Silencing SPIB in attached and floating state of H1703 lung cancer cells 1.09
The Polycomb Repressor Complex 1 Drives Double-Negative Prostate Cancer Metastasis by Coordinating Stemness and Immune Suppression 1.09
Defective transcription elongation in a subset of cancers confers immunotherapy resistance 1.05
ZBTB10 binds the telomeric variant repeat TTGGGG and interacts with TRF2 1.02
ZBTB10 binds the telomeric variant repeat TTGGGG and interacts with TRF2 [RNA-Seq] 1.02
Transcriptome analysis of immature and matured human oocytes from patients of young and advanced maternal age 1.01
Transcriptome profiling of CXCR2+ neuroendocrine (NE) tumor cells purified from patients' fresh prostate adenocarcinoma 1.01
Transcriptional landscape of epithelial and immune cell populations revealed through FACS-seq of healthy human skin 1.0
Super-enhancer-driven CCAT1 is co-activated by SOX2 and TP63 and promotes squamous cancer from esophagus, head and neck and lung 0.99
Super-enhancer-driven CCAT1 is co-activated by SOX2 and TP63 and promotes squamous cancer from esophagus, head and neck and lung [RNA-seq] 0.99
Identifying lincRNA as prognostic biomarker for clear cell renal cell carcinoma 0.99
Potential signaling pathways and gene signatures associated with brain metastases in NSCLC patients 0.98
Histone Demethylase-Assisted Somatic Cell Nuclear Transfer Facilitates Derivation of Human Pluripotent Stem Cells 0.98
Modeling the MYC-driven normal-to-tumour switch in breast cancer. 0.97
Global Promotion of Alternative Internal Exon Usage by mRNA 3' End Formation Factors 0.95
Global Regulation of Alternative Internal Exon Usage by mRNA 3' End Formation Factors [RNA-Seq] 0.95
A non-catalytic function of carbonic anhydrase IX contributes to the glycolytic phenotype and pH regulation in human breast cancer cells 0.94
Targeting Taxane-Platin Resistant Lung Cancers with JumonjiC Lysine Demethylase Inhibitors (RNA-Seq) 0.94
Targeting Taxane-Platin Resistant Lung Cancers with JumonjiC Lysine Demethylase Inhibitors 0.94
Conservative alteration of chromosomal expression pattern across human solid tumor types 0.91
G-quadruplex structures mark human regulatory chromatin 0.91
RNA-seq of cancer cell lines treated with T-025 0.9
Determining effects of microbial metabolite, Urolithin A on colon epithelial cells 0.9
RNA-seq analysis of the role of HBO1 (KAT7/MYST2) in the ovarian cancer cell line UWB1.289. 0.89
Grainyhead-like 2 (GRHL2) and epigenetic remodeling in the intermediate states of epithelial-mesenchymal transition [RNA-seq] 0.89
Grainyhead-like 2 (GRHL2) and epigenetic remodeling in the intermediate states of epithelial-mesenchymal transition 0.89
Luminal lncRNAs Regulation by ERα-controlled Enhancers in a Ligand-independent Manner in Breast Cancer Cells 0.88
Genetic disruption of COX-1 inhibits multiple oncogenic pathways 0.87
Impact of DNA MMR activity on antiviral gene expression in H441 cells infected with influenza A virus 0.86
Regulation of cellular heterogeneity and rates of symmetric and asymmetric divisions in triple-negative breast cancer 0.86
Treatment of prostate cancer cells with S-adenosylmethionine leads to genomewide alterations of transcription profiles 0.85
RNA-sequencing of milk cells extracted from pre-partum secretions and longitudinally from mature human milk across the first year of lactation 0.83
T47D xenografts treated with various combinations of ER- and PR-targeting therapies 0.83
Gene expression analysis of airway epithelial cells exposed to flagellin via RNA-seq and microarray 0.83
Gene expression analysis of airway epithelial cells exposed to flagellin via RNA-seq 0.83
Molecular analysis of renal cell carcinoma with unclassfied histology 0.81
Molecular analysis of renal cell carcinoma with unclassfied histology [gene expression] 0.81
DHX36 is the missing link to understand RNA G-quadruplex structures, mRNA stability, and translation [RNA-seq] 0.8
Evaluation of the effectiveness of semen collection and sperm purification methods for spermatozoa transcript profiling 0.8
Nuclear import of the DSCAM-cytoplasmic domain drives signaling capable of inhibiting synapse formation 0.8
The Genomic Landscape of Atypical Fibroxanthoma 0.77
RNAseq of IL-36 stimulated primary human keratinocytes 0.76
Transcriptome analysis in HT29 and SW480 cells depleted of Prdx2 0.76
Epigenome regulation during epidermal lineage commitment [RNA-seq] 0.75
RNA sequencing for PDX1, NGN3 and MAFA transduced iPSCs cell 0.75
Patient-derived organoids (PDOs) model treatment response of metastatic gastrointestinal cancers. 0.74
Bromodomain-containing Protein 4 (BRD4) is Required for the Maintenance of a Mammary Epithelial Phenotype 0.74
Bromodomain-containing Protein 4 (BRD4) is Required for the Maintenance of a Mammary Epithelial Phenotype [RNA-Seq] 0.74
Rna-seq transcriptome data for insulin-GFP+ cells differentiated from NEUROD1 knock out and NEUROD1+/+ control human embryonic stem cells. 0.74
NEUROD1 dependent gene regulation in murine pancreatic endocrine cells and human stem cell derived insulin producing cells 0.74
The lung-enriched p53 mutants V157F and R158L/P regulate a novel transcriptome in lung cancer 0.73
THZ1 targeting CDK7 suppresses STAT transcriptional activity and sensitizes T-cell lymphomas to BCL2 inhibitors 0.73
Hyperactive mTOR and MNK1 phosphorylation of eIF4E confer tamoxifen resistance and estrogen independence through selective mRNA translation reprogramming 0.73
Illumina sequencing of vaginal epithelial cells from women using depot medroxyprogesterone acetate or non-hormonal contraception 0.73
Interferon receptor signaling pathways regulating PD-L1 and PD-L2 expression 0.72
Chromatin-informed inference of transcriptional programs in gynecologic cancers 0.72
Chromatin-informed inference of transcriptional programs in gynecologic cancers [RNA-Seq] 0.72
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 0.72
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 (RNA-Seq) 0.72
Effects of Polybrominated Diphenyl Ether (PBDE) Mixture on estrogen receptor positive (ER+) patient-derived tumor xenograft (PDX) model 0.72
Transcriptome of invasive mucinous adnocarcinoma of the lung and adjacent normal lung tissues from 6 patients based on RNA-seq method 0.71
Molecular analysis of high-grade serous ovarian carcinoma with and without associated serous tubal intra-epithelial carcinoma [RNA-Seq; normal samples] 0.71
RNA-seq analysis identifies different transcriptomic types and developmental trajectories of primary melanomas 0.71
Retroviral Replicating Vectors Deliver Cytosine Deaminase Leading to Targeted 5-FU-Mediated Cytotoxicity in Multiple Human Cancer Types 0.7
RNA sequencing of human pancreatic cancer cell lines 0.7
Long-term in vitro expansion of epithelial stem cells enabled by pharmacological inhibition of PAK1-ROCK-Myosin II and TGF-β signaling 0.69
Long-term in vitro expansion of epithelial stem cells enabled by pharmacological inhibition of PAK1-ROCK-Myosin II and TGF-β signaling (RNA-seq) 0.69
RNA-seq and flow-cytometry of conventional, scalp, and palmoplantar psoriasis reveal shared and distinct molecular pathways 0.69
Bulk RNA-sequencing of cell types isolated by FACS from normal human prostates 0.68
Ewing sarcoma resistance to SP-2509 is not mediated through KDM1A/LSD1 mutation I 0.68
RUNX2/CBFB modulates the response to MEK inhibitors through activation of receptor tyrosine kinases in KRAS mutant colorectal cancer 0.68
A Basal Stem Cell Signature Identifies Aggressive Prostate Cancer Phenotypes 0.68
High throughput characterization of the m6A demethylase FTO by CLIP and RNAseq 0.67
Transcriptome response to 4h IL-1b stimulation of primary chondrocytes 0.67
Co-regulation of splicing by Rbfox1 and hnRNP M 0.67
Co-regulation of splicing by Rbfox1 and hnRNP M [hnRNPM k-d+Rbfox1 RNA-Seq] 0.67
Overexpression of NFIB and YBX1 in MCF-7 cells 0.66
Ectoderm specification of H1 human embryonic stem cells 0.65
RNA-Seq analysis of primary human keratinocytes exposed to Cannabidiol 0.65
AR-independent prostate cancer is sustained through FGF signaling 0.65
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation [cPDS-RNA-seq] 0.63
Gene expression analysis upon mtDNA depletion [RNA-seq] 0.62
Gene expression analysis upon mtDNA depletion 0.62
EZHIP constrains Polycomb Repressive Complex 2 activity in germ cells (RNA-Seq) 0.62
EZHIP constrains Polycomb Repressive Complex 2 activity in germ cells 0.62
Self-organized amniogenesis by human pluripotent stem cells in a biomimetic implantation-like niche 0.62
Identification of global XBP1s target gene expression in human prostate cancer cells 0.6
Single-cell transcriptomics of human oocytes: environment-driven metabolic competition and compensatory mechanisms during oocyte maturation 0.6
Human Induced Pluripotent Stem Cells Recapitulate Breast Cancer Patients’ Predilection to Doxorubicin-Induced Cardiotoxicity 0.56
An Alternative Splicing Event Amplifies Evolutionary Differences Between Vertebrates 0.56
Evaluating and comparing the Transcriptome of (human) Hek 293 based cells, expressing either CHD3 or CHD4 0.56
Mutation independent activation of the Notch pathway is associated with Lapatinib resistance in Her2+ breast cancer cell lines 0.55
mRNA sequencing analysis of cultured human primary airway epithelial cells upon exposure to PMN exosomes 0.55
Expression profiling of pancreatic adenocarcinoma and ductal adenocarcinoma cell lines. 0.54
Temporal dynamic reorganization of 3D chromatin in hormone-induced breast cancer and endocrine resistance 0.53
RNA isoform screens reveal the essentiality and tumor suppressor activity of ultraconserved poison exons 0.52
The serine hydroxymethyltransferase-2 (SHMT2) initiates lymphoma development through epigenetic tumor suppressor silencing. 0.51
Gene expression profiling in follicular lymphoma (FL) samples and paired transformed follicular lymphoma (tFL) (n=6 samples) 0.51
Human gut derived-organoids as model to study gluten response and effects of microbiota bioproducts in celiac disease 0.51
The Wnt/β-catenin and RAS-ERK Pathways were Activated in Tissues of Chemotherapy-Resistant Gastric Cancer PDX Tumor 0.5
Transcriptomic analysis of T84 colon carcinoma cell line treated with trametinib, JQ1 or their combination 0.5
RNA m5C Methylation in breast cancer using MeRIP-Seq 0.5
Epigenetic modulation of β-cells by interferon-α via PNPT11-miR-26a-TET2 triggers autoimmune diabetes 0.49
Epigenetic modulation of β-cells by interferon-α via PNPT11-miR-26a-TET2 triggers autoimmune diabetes [RNA-seq] 0.49
HEK293 TFAM Knockout Expression Study 0.49
Gene Expression of Breast Cancer Cell Lines Across Biomaterial Platforms 0.49
Mucosal Profiling of Pediatric-Onset Colitis and IBD Reveals Common Pathogenics and Therapeutic Pathways 0.49
Hypoxic transcriptome of SQ20B human head and neck cancer cells 0.48
BAF controls genome accessibility 0.48
Energy Metabolism during Anchorage-Independence 0.48
Pre-mRNA Splicing is Facilitated by an Optimal RNA Polymerase II Elongation Rate 0.48
Lysine benzoylation is a novel histone mark 0.48
Lysine benzoylation is a novel histone mark [RNA-seq] 0.48
The secretome of skin cancer cells activates the mTOR/MYC pathway in healthy keratinocytes and converts them into tumorigenic cells 0.47
A transcriptome dataset revealing the molecular features of breast cancer stem cells 0.47
NHLRC1 re-expression in cancer cells 0.46
Functional Comparison of the HGF/Met and MSP/Ron Systems in a Pancreatic Cancer Model 0.46
Adaptation of the Kinome Promotes Resistance to BET Bromodomain Inhibitors in Ovarian Cancer 0.46
Differential Protein Occupancy Profiling of the mRNA Transcriptome 0.46
MOV10 Is a 5' to 3' RNA Helicase Contributing to UPF1 mRNA Target Degradation by Translocation along 3'UTRs (expression) 0.46
MOV10 Is a 5' to 3' RNA Helicase Contributing to UPF1 mRNA Target Degradation by Translocation along 3'UTRs 0.46
Neonatal and adult human testis defined at the single-cell level 0.45
Molecular Biomarkers Screened by Next-generation RNA Sequencing for non-sentinel lymph node status predicting in breast cancer patients with metastatic sentinel lymph node 0.45
Differentially expressed genes post knock down of lincDUSP26 0.45
A genome-wide long noncoding RNA CRISPRi screen identifies PRANCR as a novel regulator of epidermal homeostasis 0.45
Virus-like vesicles of Kaposi’s Sarcoma-Associated Herpesvirus activate lytic replication through triggering differentiation signaling 0.44
Virus-like vesicles of Kaposi’s Sarcoma-Associated Herpesvirus activate lytic replication through triggering differentiation signaling (mRNA) 0.44
Combined Genome and Transcriptome Sequencing to Identify Allelic Selection in Epithelial Ovarian Cancer 0.43
Quantitative comparison between cellular mRNAs and exosomal mRNAs in human iPSC-derived motor neurons 0.43
Radiomic and gEnomic approaches for the enhanced DIagnosis of REnal Cancer (REDIRECt): A translational pilot study 0.43
RNA-sequencing (RNA-seq) in BxPC-3 and S2-007 cell lines 0.43
The E3 ubiquitin ligase HectD1 suppresses EMT and metastasis by targeting the +TIP protein ACF7 for degradation 0.42
RNA-seq of H1299 cells in which either PRKCI or SOX2 was silenced by validated lentiviral shRNA constructs 0.42
Analyses of T-ALL (COG study) 0.42
RNA sequencing of T-ALL (COG study) 0.42
Leukodystrophy-associated POLR3A mutations down-regulate the RNA polymerase III transcript and important regulatory RNA BC200 0.42
SILAC identifies LAD1 as an oncogenic filamin binder regulating actin dynamics in response to EGF and marking aggressive breast tumors 0.42
Time-Resolved Proteomics Extends Ribosome Profiling-Based Measurements of Protein Synthesis Dynamics 0.4
Gene expression analysis of ER+ and ER- breast cancer cell lines with acquired resistance to palbociclib 0.4
Metastasis in triple negative breast cancer is dependent on ΔNp63/CXCL2/CCL22-mediated recruitment of myeloid-derived suppressor cells 0.4
AKT Inhibition Promotes Non-autonomous Cancer Cell Survival 0.4
AKT Inhibition Promotes Non-autonomous Cancer Cell Survival [RNA-Seq] 0.4
Developing a Novel Two-Dimensional Culture System to Enrich Human Prostate Luminal Progenitors That Can Function as a Cell of Origin for Prostate Cancer 0.4
Unbiased evaluation of cell-free amniotic fluid transcriptome of term and preterm infants to detect fetal maturity 0.4
Evidence for HOXC6 as a potential molecular marker for non-small cell lung cancer 0.39
Expression profile of MM.1S tumors folloiwing treatment with bortezomib 0.39
H1609088 Human RNA-Sequencing 0.38
Widespread N6-methyladenosine-dependent RNA Structural Switches Regulate RNA-Protein Interactions 0.38
Diverse Compounds from Pleuromutilin Lead to a Thioredoxin Inhibitor and Inducer of Ferroptosis 0.38
Treatment of multiple myeloma cells with EZH2 small molecule inhibitor 0.38
Long Non-coding RNA PICSAR Promotes Growth of Cutaneous Squamous Cell Carcinoma by Regulating ERK1/2 Activity 0.38
Human Nonsense-Mediated RNA Decay Initiates Widely by Endonucleolysis and Targets snoRNA Host Genes 0.38
Uridilation by TUT4/7 restricts retrotransposition of human Line-1s 0.38
SIX4 acts as a master regulator of genes associated with the malignant phenotype of non-small cell lung cancer cells 0.38
Gene expression in PANC1 cells treated with Rakicidin 0.37
STVI-120 Induction of differentiation in human epidermal stem cells followed by differential splicing analysis 0.37
The Wnt/β-catenin-signaling pathway is modulated by androgen ablation therapy for advanced clinical prostate cancer and contributes to androgen independent cell growth 0.37
Cell differentiation grade determines distinct FOXA2 contributions to the cis-regulatory networks of pancreatic cancer cells 0.37
Cell differentiation grade determines distinct FOXA2 contributions to the cis-regulatory networks of pancreatic cancer cells [RNA-seq] 0.37
Gene expression alterations of pancreatic intraepithlial neoplasia 0.36
LncRNA NMR knockdown and overexpression in esophageal squamous cell carcinoma cell lines 0.36
Small-molecule-based Human Genome G4 Profiling Reveals Potential Gene Regulation Activity 0.36
The gene expression profiles of gallbladder cancer 0.36
The ZZ-type zinc finger of ZZZ3 modulates the ATAC complex-mediated histone acetylation and gene activation 0.35
Aberrant expression profile of lncRNA and mRNA in dilated cardiomyopathy by RNA-sequence 0.35
Obstructed defecation – an enteric neuropathy? An exploratory study of patient samples 0.33
Endogenous interaction profiling identifies DDX5 as an oncogenic coactivator of transcription factor Fra-1 0.33
Endogenous interaction profiling identifies DDX5 as an oncogenic coactivator of transcription factor Fra-1 [RNA-seq] 0.33
Dnmt3a and Dnmt3b associate with enhancers to regulate human epidermal stem cell homeostasis 0.33
RNA sequencing of CACO-2 cells incubated with bifidobacteria grown on human milk oligosaccharides. 0.33
RNAseq of ribosomal fractionation to assess the effect of CBFB on translation regulation 0.32
Bi-allelic Alteration and Dysregulation of the Hippo Pathway in Mucinous Tubular and Spindle Cell Carcinoma of the Kidney 0.32
Modeling Trilateral Retinoblastoma using Human Embryonic Stem Cells 0.31
Molecular characterization of gene regulatory networks in primary human tracheal and bronchial epithelial cells. 0.31
Polysome profiling RNAseq of cells transfected with an oligonucleotide targeting the ES6S region of the 40S subunit 0.31
JAK dependent survival of ALK- ALCL 0.31
Human islets of varying quality: the good, the (not so) bad and the ugly 0.31
Diarrhea in lymphocytic colitis: ERK1/2-dependent ENaC dysregulation and claudin-4-, -5- and -8-related barrier defects 0.31
circRNA profile in hypopharyngeal cancer 0.31
Differential gene expression by suppression of either SOX2 or TP63 in KYSE70 human esophageal squamous carcinoma cell line. 0.31
PTHrP overexpression in MCF7 cells 0.31
RNA-Seq of human PDA cell lines transfected with control siRNA or Pdx1 siRNA 0.3
Cohesin and CTCF Differentially Affect the Chromatin Architecture and Gene Expression in Human Cells 0.3
Gene expression analysis of human adenomas. 0.29
Epigenome regulation during epidermal lineage commitment 0.29
Polycomb complexes associate with enhancers to promote oncogenic transcriptional programs in cancer 0.29
Neurofibromin is an Estrogen Receptor alpha Transcriptional Co-repressor in Breast cancer 0.29
Single-cell Transcriptomics reveals multi-step adaptations to endocrine therapy 0.29
Transcriptional control of subtype switching ensures adaptation and growth of pancreatic cancer 0.29
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT and labelled with 4SU 0.29
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT, U0126, CYHX, ActD, EGF, FGF, or IGF and labelled with 4SU 0.29
Cistromic re-programming by truncating GATA3 mutations promotes mesenchymal transformation in vitro, but not mammary tumour formation in mice [RNA-seq] 0.29
Cistromic re-programming by truncating GATA3 mutations promotes mesenchymal transformation in vitro, but not mammary tumour formation in mice 0.29
Transcriptome-wide analysis links the short-term expression of the b isoforms of T-cell intracellular antigens to protective proteostasis-mediated survival and quiescence 0.28
Effects of Inhibition of CDK8/19 Mediator Kinase by Senexin B in HEK293 cells treated with or without TNF-alpha 0.28
Comparison of 7 small cell lung cancer PDX models, cultured ex vivo, for response to LSD1 inhibitor RG6016/ORY1001 0.28
RNA-seq data of small cell carcinoma of the bladder (SCCB) /urothelial carcinoma (Non-SCCB) clinical samples, and bladder-PARCB cell lines 0.28
Next Generation Sequencing Analysis of Colorectal Cancer Tissue Transcriptomes 0.28
Xeno-free and Chemically Defined Human System for Culturing Human Epidermal Keratinocytes 0.28
Next Generation Sequencing Facilitates Quantitative Analysis of ALDH+ E-BCSC, CD24-CD44+ M-BCSC and Bulk tumor cell Transcriptomes from MC1 and Vari068 PDX models of TNBC 0.28
HIV-1 perturbs homeostatic ILCs, unmasks ILC1 plasticity, and boosts TCF7+ memory NK cells 0.27
Global response to chemotherapy-induced apoptosis 0.26
TALEN-based knockout of mir-141 and mir-200c in SK-BR-3 cells 0.26
Mesothelioma xenografts in nude mice: PBS treated versus pirfenidone treated 0.26
Altered Hydroxymethylation is seen at regulatory regions in pancreatic cancer and regulates oncogenic pathways [RNA-seq] 0.26
Altered Hydroxymethylation is seen at regulatory regions in pancreatic cancer and regulates oncogenic pathways 0.26
Global Long Terminal Repeat activation participates in establishing the unique gene expression program of classical Hodgkin Lymphoma [Primary RNA-Seq] 0.25
Single-cell survey of human lymphatics unveils marked endothelial cell heterogeneity and mechanisms of homing for neutrophils 0.25
The MEF2B Regulatory Network 0.25
The MEF2B Regulatory Network - RNA-seq data 0.25
Integrated Multi-omic Analysis of Esthesioneuroblastomas Identifies Two Subgroups Linked to Cell Ontogeny 0.25
Gene expression profile of human iPSC-derived nephron progenitor cells 0.25
Genome-wide expression from the esophageal biopsies of subjects with and without eosinophilic esophagitis 0.25
RNA profiling Analysis of the Serum Exosomes Derived from Active and Latent M.tuberculosis infectious Patients 0.24
Genome-wide RNA-sequencing of human islets 48 hour after transduction with adenoviruses expressing either GFP (control), or histone chaperone ASF1B. 0.24
Intrinsic histone acetyltransferase activity of BRD4 is responsible for nucleosome eviction and transcriptional activation 0.24
Persistence of stem cell metabolism in cancers as a failure of differentiation 0.23
A cell-permeable stapled peptide inhibitor of the estrogen receptor/coactivator interaction 0.22
Integrative analysis identifies targetable CREB1/FoxA1 transcriptional co-regulation as a predictor of prostate cancer recurrence 0.22
Gene Expression Profiling of Cutaneous CD30+ Lymphoproliferative Disorders by RNA-seq 0.22
Next generation sequencing of the transcriptome in MCF-7 cells with/without SRA knockdown 0.21
Cis-SAGe fusion RNAs in transcription splicing factors knocking-down 293T cells 0.21
IRF2 is a master regulator of human keratinocyte stem cell fate [RNA-seq] 0.2
IRF2 is a master regulator of human keratinocyte stem cell fate 0.2
Inhibition of ERG Activity in Patient Derived Prostate Cancer Xenografts using the Small Molecule Inhibitor YK-4-279 0.2
Evaluation of RNA amplification and RNA-Seq library preparation protocols for spermatozoa RNA profiling 0.2
FMRP-associated MOV10 facilitates and antagonizes miRNA-mediated regulation 0.2
Short-term effect of Boost versus Radical doses of Intraoperative electron Radiotherapy in breast cancer tumor bed using high-throughput approaches 0.2
Circular RNA expression signature of low-glucose-treated MIA PaCa-2 cells 0.2
Gene expression profiling by RNA-seq of SW480 TGM2 knockdown cells 0.2
Next-generation RNA sequencing to determine changes in gene expression during breast cancer progression 0.2
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [Toxin] 0.2
ML29755 RNA-seq data 0.19
Gene expression profiling of patient's DCIS-IDC tandem lesions by RNA sequencing analysis 0.19
RNA seq analysis of human Fetal and adult derived Enterospheres 0.19
Germline NLRP1 mutations cause skin inflammatory and cancer susceptibility syndromes via inflammasome activation 0.19
A robust qualitative transcriptional signature for the early diagnosis of gastric cancer 0.18
Determination of a comprehensive alternative splicing regulatory network and the combinatorial regulation by key factors during Epithelial-to-Mesenchymal Transition [ESRP KD] 0.18
Transcriptomic analyssis following EHMT1/2 inhibition 0.18
Transcriptomic analysis to functionally map the intrinsically disordered domain of EWS/FLI [Experiment 1] 0.18
CD86 regulates a pro-survival signal in myeloma cells 0.18
The contribution of Alu exons to the human proteome 0.17
RNA-seq in endometrial stromal tumors 0.17
Cystathionine-β-Synthase Promotes Colon Carcinogenesis 0.17
TUT-DIS3L2 is a mammalian surveillance pathway for aberrant structured non-coding RNAs. 0.16
Uridylation-mediated RNA quality control pathway in mammalian cytoplasm [RNA-Seq] 0.16
Transcriptome sequencing after MAGOHB knockdown in MAGOH-deleted or non-deleted cancer cells 0.16
Single-cell RNA-seq reveals novel cell differentiation dynamics during human airway epithelium regeneration 0.16
Gene expression activation in CLL mediated by MSCs contact 0.16
shRNA knockdown of YAP1 in HCC364 cells, various drug conditions 0.15
RNA-seq in SUNE-1 cells after downregulation of DANCR expression 0.15
Generation and persistence of human tissue-resident memory T cells in lung transplantation 0.15
Poly(A)-ClickSeq resolves CF25-mediated alternative poly-adenylation, HeLa 0.15
RNA-sequencing analysis of 5' capped RNAs identifies novel differentially expressed genes in sessile serrated colon polyps (SSPs) 0.14
Gene expression profiling in metabolically heterogeneous human lung tumors 0.14
ERBB3 and NGFR mark distinct skeletal muscle progenitor cells in human development enabling enrichment and maturation of hPSC muscle 0.14
RNA-seq of exosomes identifies lncRNA profiles that distinguish early-stage esophageal squamous cell carcinoma (ESCC) from non-malignant esophagitis 0.14
RUVBL1/RUVBL2 ATPase Activity Drives PAQosome Maturation, DNA Replication and Radioresistance in Lung Cancer 0.14
CUREfast: Accelerating research with families 0.13
Patient Derived Xenograft for Delivery of Precision Medicine in Castrate Resistant Prostate Cancer 0.13
Expression and functions of long noncoding RNAs during human T helper cell differentiation 0.13
PANCR, the PITX2 adjacent noncoding RNA, is specifically expressed in human left atria and regulates PITX2c expression 0.13
RNA-Seq analysis of Head and Neck Squamous cell carcinoma cell-lines 0.13
The effect of Abl kinases on non-small cell carcinoma global transcriptome 0.13
APOBEC mutation drives early-onset squamous cell carcinomas in recessive dystrophic epidermolysis bullosa 0.12
CDK4/6 inhibitor resistance in prostate cancer 0.12
Biomarkers of Cavernous Angioma with Symptomatic Hemorrhage (CASH) [RNA-seq] 0.12
Biomarkers of Cavernous Angioma with Symptomatic Hemorrhage (CASH) 0.12
RNA-Seq analysis of cSCC cells followed by siRNA-induced gene knockdown of C1s. 0.12
High-throughput RNA sequencing on circular RNA profiles of human triple-negative breast cancer and adjacent normal tissues 0.12
Enhancer Sequence Variants and Transcription Factor Deregulation Synergize to Construct Pathogenic Regulatory Circuits in B Cell Lymphoma (RNA-Seq) 0.12
Enhancer Sequence Variants and Transcription Factor Deregulation Synergize to Construct Pathogenic Regulatory Circuits in B Cell Lymphoma 0.12
Activating Transcription Factor 4 modulated TGFb-induced aggresiveness in triple negative breast cancer vis SMAD2/3/4 and mTORC2 signaling 0.11
Deep sequencing of transcript levels of human embryonic stem cell derived mesothelium (epithelial and mesenchymal forms) and mesothelium from neonatal mouse E15.5 of the heart, lung, liver and gut and ChIP-seq data of the mesenchymal form of mesothelium 0.11
Genomic profiling of biliary tract cancer cell lines reveals molecular subtypes and actionable drug targets 0.1
KLF4 as a rheostat of osteolysis and osteogenesis in prostate tumors in the bone 0.1
CXCR4 regulates extra-medullary myeloma through epithelial-mesenchymal transition-like transcriptional activation 0.1
The Molecular Dissection of the Oncogenic Role of ETS1 in the Mesenchymal Subtypes of Head and Neck Squamous Cell Carcinoma [RNA-seq Cell lines] 0.09
Azithromycin induces epidermal differentiation and multivesicular bodies in airway epithelia 0.09
Transcriptomics analysis of human jejunal enteroendocrine cells after vertical sleeve gastrectomy 0.09
Transcriptomics analysis of enteroendocrine cells following vertical sleeve gastrectomy 0.09
Dissecting the single-cell transcriptome network underlying gastric premalignant lesions and early gastric cancer [10x genomics] 0.09
The expression profiles of GBC liver metastasis 0.09
Genome wide association study of bone size yields eleven loci that also affect height, bone density, osteoarthritis and fractures 0.08
Genome-wide expression profiling of an in vitro model for studying esophageal epithelial differentiation 0.07
AQP5-Expressing Cells Serve as Stem Cells and Cancer Origins in the Distal Stomach 0.07
CDK12 regulates alternative last exon mRNA splicing and promotes invasion of a breast cancer cell line 0.07
Targets of ROR2 overexpression in MCF-7 cells revealed a differentially regulated module of non-canonical WNT signaling pathway 0.07
Targeting miR-155 restores abnormal microglia and attenuates disease in SOD1 mice 0.07
miR-155 plays a crucial role in ALS and is an immune therapeutic target [RNA-Seq] 0.07
Efficient and precise editing of endogenous transcripts with SNAP-tagged ADARs 0.07
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. [RNA-Seq] 0.07
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. 0.07
Mutant p63 disrupts the key specification switch from the multipotent cell state to stratified epithelia during epithelial differentiation/in ectodermal dysplasia disorders 0.06
Transcriptome analysis of V336Y mutant mitochondrial ribosomal protein in human HEK293 cell line 0.06
Defective transcription elongation in a subset of cancers confers immunotherapy resistance (BGI12 RNA-Seq) 0.06
RNA Sequencing Analysis of villus tissues from unexplained recurrent spontaneous abortion patients and controls with induced abortions 0.06
Quantitative profiling of the UGT transcriptome in human drug metabolizing tissues [Total RNA] 0.06
RNA-seq of HDAC2-disrupted 293FT cells by CRISPR-Cas9 0.05
Transcriptome analysis of RANK-positive and RANK-negative luminal progenitor subpopulations in the human breast 0.05
Gene expression profiles of 4-1BB+PD-1-high, 4-1BB-PD-1-high, and PD-1-int tumor-infiltrating CD8 T cells in hepatocellular carcinoma 0.05
Whole transcriptome splicing analysis in isogenic lung epithelial and adenocarcinoma cell lines with or without a recurrent splicing factor mutation, U2AF1 (S34F) 0.05
Genome wide impact of loss of mechanoluminal stimulation on neonatal intestine 0.05
Transcriptome analysis upon C6orf203 silencing 0.05
MCF-7 as a model for functional analysis of breast cancer risk variants 0.05
A runaway PRH/HHEX-Notch3 feedback loop drives cholangiocarcinoma (RNA-Seq) 0.04
RNA sequencing from FOXM1 knockout HEK293T cells reconstituted with FOXM1 isoforms a, b and c. 0.04
Transcriptomic Analysis Of circRNAs/miRNAs/mRNAs upon Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection 0.04
RNA-seq in neurons derived from iPSCs in controls and patients with schizophrenia and 22q11 del 0.04
Profiling gene expression changes in primary ovarian tumors compared to matched normal fallopian tubes 0.03
RNAseq of Breast cancer PDX samples 0.03
β-Caryophyllene Enhances the Transcriptional Upregulation of SREBP-dependent Lipid Biosynthesis in Breast Cancer Cells 0.03
The role of the Calcium-Sensing receptor in colorectal cancer 0.03
RNA sequencing of prostate cancer and normal tissue from African Americans and European Americans 0.02
Low H3K27me3 and DNA hypomethylation define poorly prognostic pediatric posterior fossa ependymomas 0.02
Epigenetic changes induced by Bacteroides fragilis toxin (BFT) 0.02
Epigenetic changes induced by Bacteroides fragilis toxin (BFT) [RNA-seq] 0.02
Generation of low passage high grade serous ovarian cancer cell lines from primary tumors 0.02
Circular RNAs are super abundant in cervical tumor and plasma detected by high throughput microarray 0.02
Circular RNAs are super abundant in cervical tumor and plasma detected by high throughput microarray [RNA-Seq] 0.02
Pancreatic Beta Cell Enhancers Regulate Rhythmic Transcription of Exocyst Triggering and Diabetes 0.02
Genome-wide Circadian Control of Transcription at Active Enhancers Regulates Insulin Secretion and Diabetes Risk 0.02
RNA sequencing of lesional and nonlesional skin from patients with atopic dermatitis 0.02
A single-cell transcriptome atlas of the human pancreas 0.01
Divergent expression and metabolic functions of human glucuronosyltransferases through alternative splicing 0.01
Illumina HiSeq Sequencing on Breast cancer PDX samples 0.01
Stapled peptide inhibitors of RAB25 target context-specific phenotypes in cancer 0.01
Dexamethasone inhibits respiratory syncytial virus-driven mucus production while increasing viral replication without altering antiviral interferon signaling 0.01
Immunophenotyping and Transcriptomic Outcomes in PDX-Derived TNBC Tissue 0.01
Identification of Differentially Expressed Splice Variants by the Proteogenomic Pipeline Splicify 0.01
Gene expression analysis of breast cancer cell-lines 0.01
Gene expression and genome-wide location analysis of breast cancer cell-lines 0.01
Cutaneous Immunoprofile of Three Spotted Fever Group Rickettsiosis 0.01
A specific missense mutation in GTF2I occurs at high frequency in thymic epithelial tumors 0.01
Ribosomal protein RPL26 is the principal target of UFMylation 0.0
RNA-sequencing analysis examining how the Vibrio cholerae MARTX toxin and its inidividual effector domains modulate the transcriptome of human intestinal epithelial cells. 0.0
RNA sequencing analysis of selumetinib-resistant CRC cells lines 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation